Isofol Medical AB (publ)
ISOFOL SE0009581051
ICB 2010 : Health Care / Health CareAnnual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-58% | -92% | -1% | 211% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Margareta Hagman CFO |
2.56 SEK |
40,000 Bought |
102,400 SEK |
23/09/2024 | 23/09/2024 |
Magnus Hurst CFO |
2.57 SEK |
35,500 Sold |
91,235 SEK |
16/09/2024 | 13/09/2024 |
Petter Segelman Lindqvist CEO |
2.69 SEK |
7,777 Bought |
20,956 SEK |
21/08/2024 | 21/08/2024 |
Petter Segelman Lindqvist CEO |
2.47 SEK |
7,777 Bought |
19,170 SEK |
12/07/2024 | 12/07/2024 |
Petter Segelman Lindqvist CEO |
0.94 SEK |
7,777 Bought |
7,287 SEK |
05/07/2024 | 05/07/2024 |
Petter Segelman Lindqvist CEO |
0.80 SEK |
6,348 Bought |
5,091 SEK |
27/03/2024 | 26/03/2024 |
Magnus Hurst CFO |
0.69 SEK |
35,000 Bought |
24,150 SEK |
11/01/2024 | 11/01/2024 |
Ab Windar CEO |
0.61 SEK |
500,000 Bought |
305,000 SEK |
12/09/2022 | 12/09/2022 |
Robert Marchesani DIR |
20.90 SEK |
2,869 Bought |
59,962 SEK |
26/06/2019 | 26/06/2019 |
Robert Marchesani DIR |
20.80 SEK |
1,186 Bought |
24,669 SEK |
26/06/2019 | 26/06/2019 |